When the blood-thinner drug Pradaxa (dabigatran) was FDA-approved in 2010 to prevent stroke in people at high risk, a major selling point was that it doesn't require frequent blood tests and dose adjustments like the old standby drug, warfarin.
from WebMD Health http://ift.tt/1pTGX5q
via IFTTT
from WebMD Health http://ift.tt/1pTGX5q
via IFTTT
No comments:
Post a Comment